Gene · 11034
Papers1,526
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,526
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DSTN Hypomethylation Promotes Radiotherapy Resistance of Rectal Cancer by Activating the Wnt/β-Catenin Signaling Pathway. | Int J Radiat Oncol Biol Phys | 2023 | 37019366 | PubTator, text mining | PubMed |
| Central versus peripheral mechanisms of cold-induced vasodilation: a study in the fingers and toes of people with paraplegia. | Eur J Appl Physiol | 2023 | 37005962 | PubTator, text mining | PubMed |
| The Antiviral Compound PSP Inhibits HIV-1 Entry via PKR-Dependent Activation in Monocytic Cells. | Viruses | 2023 | 36992512 | PubTator, text mining | PubMed |
| Manipulation of the Cellular Membrane-Cytoskeleton Network for RNA Virus Replication and Movement in Plants. | Viruses | 2023 | 36992453 | PubTator, text mining | PubMed |
| Identification of YWHAH as a Novel Brain-Derived Extracellular Vesicle Marker Post Long-Term Midazolam Exposure during Early Development. | Cells | 2023 | 36980307 | PubTator, text mining | PubMed |
| Glucocorticoid-induced thrombotic microangiopathy in paroxysmal nocturnal hemoglobinuria: A case report and review of literature. | World J Clin Cases | 2023 | 36970013 | PubTator, text mining | PubMed |
| Skewed multifractal scaling of stock markets during the COVID-19 pandemic. | Chaos Solitons Fractals | 2023 | 36969947 | PubTator, text mining | PubMed |
| Toward a biomarker panel measured in CNS-originating extracellular vesicles for improved differential diagnosis of Parkinson's disease and multiple system atrophy. | Transl Neurodegener | 2023 | 36935518 | PubTator, text mining | PubMed |
| LIM Kinases, LIMK1 and LIMK2, Are Crucial Node Actors of the Cell Fate: Molecular to Pathological Features. | Cells | 2023 | 36899941 | PubTator, text mining | PubMed |
| Inflammation modulates intercellular adhesion and mechanotransduction in human epidermis via ROCK2. | iScience | 2023 | 36890793 | PubTator, text mining | PubMed |
| Structure and function of Plasmodium actin II in the parasite mosquito stages. | PLoS Pathog | 2023 | 36877739 | PubTator, text mining | PubMed |
| From Natural Sources to Synthetic Derivatives: The Allyl Motif as a Powerful Tool for Fragment-Based Design in Cancer Treatment. | J Med Chem | 2023 | 36858050 | PubTator, text mining | PubMed |
| Multi-Omics Analyses Reveal the Mechanisms of Early Stage Kidney Toxicity by Diquat. | Toxics | 2023 | 36851058 | PubTator, text mining | PubMed |
| Effect of the Rho-Kinase/ROCK Signaling Pathway on Cytoskeleton Components. | Genes (Basel) | 2023 | 36833199 | PubTator, text mining | PubMed |
| The molecular mechanisms of apoptosis accompanied with the epigenetic regulation of the NY-ESO-1 antigen in non-small lung cancer cells treated with decitabine (5-aza-CdR). | Eur J Pharmacol | 2023 | 36822455 | PubTator, text mining | PubMed |
| Label-Free Proteomics of Oral Mucosa Tissue to Identify Potential Biomarkers That Can Flag Predilection of Precancerous Lesions to Oral Cell Carcinoma: A Preliminary Study. | Dis Markers | 2023 | 36776920 | PubTator, text mining | PubMed |
| Actin polymerisation and crosslinking drive left-right asymmetry in single cell and cell collectives. | Nat Commun | 2023 | 36774346 | PubTator, text mining | PubMed |
| Colchicine in Athero-Thrombosis: Molecular Mechanisms and Clinical Evidence. | Int J Mol Sci | 2023 | 36768804 | PubTator, text mining | PubMed |
| Short-Term Treatment with Rho-Associated Kinase Inhibitor Preserves Keratinocyte Stem Cell Characteristics In Vitro. | Cells | 2023 | 36766688 | PubTator, text mining | PubMed |
| An old friend with a new face: tRNA-derived small RNAs with big regulatory potential in cancer biology. | Br J Cancer | 2023 | 36759729 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11034/papers?page=7